Portfolio company
Healx
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
Healx develops an AI-driven drug discovery platform to identify treatments for rare diseases for pharmaceutical partners and patient advocacy groups.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Valohealth
This company develops an artificial intelligence platform for drug discovery and development to assist pharmaceutical partners in creating new medical treatments.
Recursion Pharmaceuticals
This company develops artificial intelligence platforms to discover and develop medicines for pharmaceutical partners and patients with rare diseases and cancer.
Drug Discovery
This company develops an artificial intelligence platform for automated molecular synthesis and drug discovery to assist pharmaceutical researchers in creating novel therapeutics.
Gatchealth
This company develops an artificial intelligence platform for drug discovery and risk assessment for biopharmaceutical companies and investors.
Xaira
The company develops artificial intelligence platforms to design and develop antibody-based medicines for patients with various diseases.
PharmEnable
This company develops small molecule medicines using an artificial intelligence platform for pharmaceutical partners and patients with oncology and neurology conditions.
Genorare
This company develops an encrypted artificial intelligence platform for hospitals and pharmaceutical firms to diagnose rare diseases using genomic and electronic health record data.
Sanius Health
This company provides a health data platform and wearable devices for patients with rare diseases and researchers to monitor symptoms and accelerate drug discovery.